Portal hypertension and portal hypertensive gastropathy in patients with liver cirrhosis: a haemodynamic study
- PMID: 12801039
- DOI: 10.1016/s1590-8658(03)00064-1
Portal hypertension and portal hypertensive gastropathy in patients with liver cirrhosis: a haemodynamic study
Abstract
Background/aim: The relationships between the levels of portal hypertension and the morphologic alterations of gastric mucosa in patients with liver cirrhosis--generally described as portal hypertensive gastropathy--are poorly defined.
Patients: In total, 62 patients with cirrhosis of different aetiologies, were examined by endoscopy and measurement of portal hypertension by hepatic venous pressure gradient.
Results: Portal hypertensive gastropathy was observed in 49 cases; six patients showed gastric antral vascular ectasia always associated with gastric lesions described as severe portal hypertensive gastropathy with different localizations. Hepatic venous pressure gradient showed severe portal hypertension in 37 cases, and averaged 17.7 +/- 4.3 mmHg. It was much higher in patients with severe lesions (p=0.0004). Hepatic venous pressure gradient in patients with endoscopic signs of isolated antral gastropathy was lower (p=0.04) than in those with isolated lesions in body-fundus. No relationship was found between hepatic function, as assessed by the Child-Pugh score, and portal hypertensive gastropathy.
Conclusions: The present data suggest that the severity of portal hypertensive gastropathy is related to portal hypertension, but portal hypertension is not the sole determinant of the occurrence of endoscopic abnormalities of gastric mucosa. The derangement of liver function does not appear to play any role in the occurrence of portal hypertensive gastropathy.
Similar articles
-
Review article: the management of portal hypertensive gastropathy and gastric antral vascular ectasia in cirrhosis.Aliment Pharmacol Ther. 2014 Aug;40(4):354-62. doi: 10.1111/apt.12824. Epub 2014 Jun 2. Aliment Pharmacol Ther. 2014. PMID: 24889902 Review.
-
Clinical, laboratory, and hemodynamic parameters in portal hypertensive gastropathy: a study of 254 cirrhotics.J Clin Gastroenterol. 2010 Apr;44(4):294-300. doi: 10.1097/MCG.0b013e3181b37ea1. J Clin Gastroenterol. 2010. PMID: 19730114
-
Underlying mechanism of portal hypertensive gastropathy in cirrhosis: a hemodynamic and morphological approach.J Gastroenterol Hepatol. 2009 Sep;24(9):1541-6. doi: 10.1111/j.1440-1746.2009.05871.x. J Gastroenterol Hepatol. 2009. PMID: 19743998
-
The effects of Helicobacter pylori colonization on gastric function and the incidence of portal hypertensive gastropathy in patients with cirrhosis of the liver.Am J Gastroenterol. 1996 Jul;91(7):1400-6. Am J Gastroenterol. 1996. PMID: 8678003
-
Management of gastropathy and gastric vascular ectasia in portal hypertension.Clin Liver Dis. 2010 May;14(2):281-95. doi: 10.1016/j.cld.2010.03.013. Clin Liver Dis. 2010. PMID: 20682235 Free PMC article. Review.
Cited by
-
Portal Hypertensive Gastropathy in Liver Cirrhosis: Prevalence, Natural History, and Risk Factors.Intern Med. 2022;61(5):605-613. doi: 10.2169/internalmedicine.7943-21. Epub 2022 Mar 1. Intern Med. 2022. PMID: 35228473 Free PMC article.
-
Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.World J Hepatol. 2016 Feb 8;8(4):231-62. doi: 10.4254/wjh.v8.i4.231. World J Hepatol. 2016. PMID: 26855694 Free PMC article.
-
Poor Abilities of Noninvasive Biomarkers to Assess Esophagogastric Varices and Portal Hypertensive Gastropathy.Biomark Insights. 2025 May 16;20:11772719251339185. doi: 10.1177/11772719251339185. eCollection 2025. Biomark Insights. 2025. PMID: 40386244 Free PMC article.
-
Portal hypertensive gastropathy: correlation with portal hypertension and prognosis in cirrhosis.Dig Dis Sci. 2010 Dec;55(12):3561-7. doi: 10.1007/s10620-010-1221-6. Epub 2010 Apr 21. Dig Dis Sci. 2010. PMID: 20407828
-
Effect of Helicobacter pylori and its virulence factors on portal hypertensive gastropathy and interleukin (IL)-8, IL-10, and tumor necrosis factor-alpha levels.Saudi J Gastroenterol. 2014 Mar-Apr;20(2):120-7. doi: 10.4103/1319-3767.129477. Saudi J Gastroenterol. 2014. PMID: 24705150 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical